162 related articles for article (PubMed ID: 12512149)
1. [Laminectomy for spinal cord compression occurring in hormone refractory prostate cancer].
Kinoshita H; Ogawa O; Arai Y
Hinyokika Kiyo; 2002 Nov; 48(11):725-8. PubMed ID: 12512149
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognosis of patients with paraplegia or quadriplegia because of metastatic spinal cord compression in prostate cancer.
Nagata M; Ueda T; Komiya A; Suzuki H; Akakura K; Ishihara M; Tobe T; Ichikawa T; Igarashi T; Ito H
Prostate Cancer Prostatic Dis; 2003; 6(2):169-73. PubMed ID: 12806378
[TBL] [Abstract][Full Text] [Related]
3. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
4. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
5. Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.
Saad F; McKiernan J; Eastham J
Urol Oncol; 2006; 24(1):4-12. PubMed ID: 16414486
[TBL] [Abstract][Full Text] [Related]
6. Neurologic complications of prostate cancer.
Benjamin R
Am Fam Physician; 2002 May; 65(9):1834-40. PubMed ID: 12018806
[TBL] [Abstract][Full Text] [Related]
7. Post-laminectomy long-term survival of a patient with spinal cord compression secondary to metastatic prostate cancer.
Saito S; Hoshi S; Sakai K; Chiba Y; Saito H; Hatori M; Endoh M; Arai Y
Int J Clin Oncol; 2004 Dec; 9(6):520-2. PubMed ID: 15616885
[TBL] [Abstract][Full Text] [Related]
8. Intermittent androgen deprivation therapy may prolong the duration of androgen dependence of well-differentiated prostate cancer.
Kaneko Y; Maekawa S; Arakaki R; Okada Y; Terada N; Nishimura K
Hinyokika Kiyo; 2006 Apr; 52(4):259-64. PubMed ID: 16686352
[TBL] [Abstract][Full Text] [Related]
9. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
[No Abstract] [Full Text] [Related]
10. [Laminectomy in metastasizing prostatic neoplasms with spinal cord compression].
Brand HP; Kreutz G; Brüderl RH
Helv Chir Acta; 1978 Jul; 45(3):293-6. PubMed ID: 701065
[No Abstract] [Full Text] [Related]
11. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: the role of hormonal therapy.
Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
[TBL] [Abstract][Full Text] [Related]
14. Posterolateral spinal cord decompression in patients with metastasis: an endoscopic assisted approach.
St Clair SF; McLain RF
Surg Technol Int; 2006; 15():257-63. PubMed ID: 17029184
[TBL] [Abstract][Full Text] [Related]
15. [Spinal cord compression by epidural metastases of urologic tumors].
Diego García A; Silmi Moyano A; Paez Borda A; Castaño A; Prieto Chaparro L; Gómez Ruiz JJ; Corral Rosillo J; Páramo González P; Salinas Casado J; Usón Calvo A
Arch Esp Urol; 1991 Nov; 44(9):1051-5. PubMed ID: 1807205
[TBL] [Abstract][Full Text] [Related]
16. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
Krupski TL; Foley KA; Baser O; Long S; Macarios D; Litwin MS
J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
[TBL] [Abstract][Full Text] [Related]
17. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer.
Chen YJ; Chang GC; Chen HT; Yang TY; Kuo BI; Hsu HC; Yang HW; Lee TS
Spine (Phila Pa 1976); 2007 Jul; 32(15):E413-8. PubMed ID: 17621197
[TBL] [Abstract][Full Text] [Related]
18. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.
Salonen AJ; Viitanen J; Lundstedt S; Ala-Opas M; Taari K; Tammela TL;
J Urol; 2008 Sep; 180(3):915-9; discussion 919-20. PubMed ID: 18635219
[TBL] [Abstract][Full Text] [Related]
19. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
Akaza H
BJU Int; 2007 Jan; 99 Suppl 1():10-2; discussion 17-8. PubMed ID: 17229161
[TBL] [Abstract][Full Text] [Related]
20. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
Daskivich TJ; Oh WK
Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
